Drug Information

Drug General Information
Drug ID
D0P8MG
Former ID
DCL000855
Drug Name
KDS-2000
Indication Postherpetic neuralgia [ICD9: 53.19; ICD10:B02.2, G44.847, G53.0] Discontinued in Phase 2 [536374]
Company
Kadmus Pharmaceuticals
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Agonist [536374]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 536374Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.
Ref 536374Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.